НовостиBenzingaWells Fargo Initiates Coverage On Korsana Biosciences with Overweight Rating, Announces Price Target of $44 Wells Fargo Initiates Coverage On Korsana Biosciences with Overweight Rating, Announces Price Target of $44 Benzinga 2026.11.13 12:57 (GMT+0) Открыть на Benzinga Другие новости